Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02927340
Brief Title: A Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial Lesions

First Submitted : September 26, 2016
First Submitted that Met QC Criteria : October 5, 2016
First Posted : October 7, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : March 7, 2021
Last Update Posted : March 9, 2021